Matikainen, S <br/><br/>
Retinoic acid enhances IL-1 beta expression in myeloid leukemia cells and in human monocytes.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Jul 1991 
 - 162-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine<br/>Blotting, Northern<br/>Bucladesine--pharmacology<br/>Gene Expression--drug effects<br/>Humans<br/>Interleukin-1--metabolism<br/>Isoquinolines--pharmacology<br/>Leukemia, Myeloid--metabolism<br/>Lipopolysaccharides--pharmacology<br/>Monocytes--metabolism<br/>Piperazines--pharmacology<br/>Protein Kinase Inhibitors<br/>RNA, Messenger--genetics<br/>Sulfonamides<br/>Tetradecanoylphorbol Acetate--pharmacology<br/>Transcription, Genetic--drug effects<br/>Tretinoin--pharmacology<br/>Tumor Cells, Cultured